JPS5924257A - カルボニル化ジエチレントリアミンを用いる放射性標識化合物安定化のための組成物 - Google Patents

カルボニル化ジエチレントリアミンを用いる放射性標識化合物安定化のための組成物

Info

Publication number
JPS5924257A
JPS5924257A JP58126840A JP12684083A JPS5924257A JP S5924257 A JPS5924257 A JP S5924257A JP 58126840 A JP58126840 A JP 58126840A JP 12684083 A JP12684083 A JP 12684083A JP S5924257 A JPS5924257 A JP S5924257A
Authority
JP
Japan
Prior art keywords
stabilizer
composition
radiolabeled compound
composition according
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58126840A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0211105B2 (enExample
Inventor
ネイサン・ア−ル・トゾデイコヴ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lantheus Medical Imaging Inc
Original Assignee
New England Nuclear Corp
Lantheus Medical Imaging Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Nuclear Corp, Lantheus Medical Imaging Inc filed Critical New England Nuclear Corp
Publication of JPS5924257A publication Critical patent/JPS5924257A/ja
Publication of JPH0211105B2 publication Critical patent/JPH0211105B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121—Solutions, i.e. homogeneous liquid formulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP58126840A 1982-07-12 1983-07-12 カルボニル化ジエチレントリアミンを用いる放射性標識化合物安定化のための組成物 Granted JPS5924257A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/397,501 US4411881A (en) 1982-07-12 1982-07-12 Composition and method for stabilizing radiolabeled compounds using thiocarbonylated diethylenetriamines
US397501 1982-07-12

Publications (2)

Publication Number Publication Date
JPS5924257A true JPS5924257A (ja) 1984-02-07
JPH0211105B2 JPH0211105B2 (enExample) 1990-03-12

Family

ID=23571454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58126840A Granted JPS5924257A (ja) 1982-07-12 1983-07-12 カルボニル化ジエチレントリアミンを用いる放射性標識化合物安定化のための組成物

Country Status (7)

Country Link
US (1) US4411881A (enExample)
JP (1) JPS5924257A (enExample)
CA (1) CA1205070A (enExample)
CH (1) CH655853A5 (enExample)
DE (1) DE3324593C2 (enExample)
FR (1) FR2536998B1 (enExample)
GB (1) GB2123412B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0317229U (enExample) * 1989-06-30 1991-02-20
JP2006528644A (ja) * 2003-07-24 2006-12-21 ブラッコ・イメージング・ソシエタ・ペル・アチオニ 安定な放射性医薬品組成物およびその製法

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3331159A1 (de) * 1983-08-30 1985-03-14 Hoechst Ag, 6230 Frankfurt N-(4-aminobenzoyl)-aminodicarbonsaeuren zur stabilisierung von technetium-99m-praeparaten, stabilisierte injektionspraeparate und verfahren zu ihrer herstellung
US4656280A (en) * 1984-03-07 1987-04-07 E. I. Du Pont De Nemours And Company Radioiodinated dopamine receptor ligand
GB8510726D0 (en) * 1985-04-26 1985-06-26 Amersham Int Plc Stabilised radio-labelled compounds
MC2260A1 (fr) * 1990-06-18 1993-04-26 Dow Chemical Co Formulations de produits radiopharmaceutiques,leur methode d'administration et leur procede de preparation
AU9172191A (en) * 1990-12-12 1992-07-08 Mallinckrodt Medical, Inc. Method of radioactive labelling of blood cells and kit therefor
WO1993002652A2 (en) * 1991-08-01 1993-02-18 Hybritech Incorporated Modified haptens useful as imaging and therapeutic agents
US5686058A (en) * 1992-04-30 1997-11-11 Amersham International Plc Radiolabelled nucleotide formulations stored in an unfrozen state
CA2105402C (en) * 1992-04-30 2000-04-04 Roger M. Price Radiolabelled compound formulations
US5342926A (en) * 1993-06-08 1994-08-30 The Regents Of The University Of California Analogs of cytochalasin B as radiopharmaceuticals for nuclear imaging of trans-membrane glucose transport
RU2104035C1 (ru) * 1995-02-27 1998-02-10 Физико-энергетический институт Препарат, содержащий органическое соединение, меченное бета-радионуклидом
WO1997001520A1 (en) * 1995-06-28 1997-01-16 E.I. Du Pont De Nemours And Company Composition and method for stabilizing radiolabeled organic compounds
ATE314097T1 (de) 1996-10-28 2006-01-15 Amersham Health As Kontrastmittel
US5961955A (en) 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
HUP0101921A2 (hu) * 2001-05-10 2004-01-28 Izotóp Intézet Kft Radioaktívan jelzett nukleotido/ka/t tartalmazó preparátumok és eljárás azok előállítására
US11474106B2 (en) 2015-07-08 2022-10-18 Lawrence Livermore National Security, Llc Methods for cytotoxic chemotherapy-based predictive assays
WO2018132766A1 (en) * 2017-01-12 2018-07-19 The Regents Of The University Of California Cytotoxic chemotherapy-based predictive assays for acute myeloid leukemia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919095A (en) * 1973-07-30 1975-11-11 Mobil Oil Corp Organic compositions containing antioxidant and antiwear additives
US3876550A (en) * 1974-04-15 1975-04-08 Lubrizol Corp Lubricant compositions
US4358434A (en) * 1979-12-19 1982-11-09 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
US4390517A (en) * 1979-12-19 1983-06-28 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0317229U (enExample) * 1989-06-30 1991-02-20
JP2006528644A (ja) * 2003-07-24 2006-12-21 ブラッコ・イメージング・ソシエタ・ペル・アチオニ 安定な放射性医薬品組成物およびその製法

Also Published As

Publication number Publication date
US4411881A (en) 1983-10-25
JPH0211105B2 (enExample) 1990-03-12
DE3324593C2 (de) 1986-10-23
FR2536998B1 (fr) 1988-01-22
GB2123412A (en) 1984-02-01
GB8316714D0 (en) 1983-07-20
CH655853A5 (de) 1986-05-30
DE3324593A1 (de) 1984-02-02
CA1205070A (en) 1986-05-27
FR2536998A1 (fr) 1984-06-08
GB2123412B (en) 1986-03-05

Similar Documents

Publication Publication Date Title
JPS5924257A (ja) カルボニル化ジエチレントリアミンを用いる放射性標識化合物安定化のための組成物
AU2016201367B2 (en) Stabilization of radiopharmaceutical compositions using ascorbic acid
EP0031121B1 (en) Method, composition and kit for stabilizing radiolabeled compounds
IL107560A (en) Kit for making radiopharmaceutical preparations containing the Technium-M99 complex
Baidoo et al. Synthesis of a diamine dithiol bifunctional chelating agent for incorporation of technetium-99m into biomolecules
JPS645256B2 (enExample)
BR112014003336B1 (pt) processo para a preparação de complexos de 68 ga, kit de reação e frasco para uso no referido processo
JP4338394B2 (ja) テクネチウム−９９ｍ窒化物ヘテロ錯体を含有する放射性画像診断剤
DE69532965T2 (de) Gegebenenfalls durch tc oder re radioaktiv markierte n3s2-chelate, geeignet für diagnostische oder therapeutische anwendungen
EP0835233B1 (en) Composition and method for stabilizing radiolabeled organic compounds
Loberg et al. Stability of 99mTc-labeled N-substituted iminodiacetic acids: Ligand exchange reaction between 99mTc-HIDA and EDTA
JPS6172725A (ja) ジシクロペンタジエンビス（メチルアミン）のホスホネ−ト誘導体で錯体化された放射性金属
CA1072010A (en) Technetium-99m-labeled diagnostic agent for kidney scanning and process for its manufacture
CA1230342A (en) Tc99m-phenida, radioscintigraphic agent for diagnosis of hepatobiliary disease
EP0750610B1 (en) Piperidyl-4-substituted thyrosine derivatives as scintigraphic imaging agents for the diagnosis of thrombosis
US8329879B2 (en) H3LMN compound used as radioactive agent for treatment of liver cancer and manufacturing method thereof
US4894218A (en) Therapy agents, methods of preparation, and methods of use
Foye et al. Antiradiation compounds XVII: Binding ability of radiation‐protective N‐heterocyclic aminoethyl disulfides and thiosulfates to DNA
CA1198549A (en) Stabilization of radiolabeled organic compound
WO2003044031A1 (en) Technetium or rhenium complexes, radiopharmaceutical products comprising them
Maina et al. Synthesis, radiochemistry and biological evaluation of technetium-99m complexes with 1, 8-diamine-3, 6-dithiaoctane (DDO) ligands
Castronovo Pharmaceutical toxicity as a function of biodegradability
Jeong et al. N, N′, N ″, N‴‐tetraalkylcyclam derivatives: synthesis, 99mTc‐labelling and biological properties
JP2004115447A (ja) グアニジノ基を有する放射性遷移金属錯体
JPH08507528A (ja) 放射線撮影イメージング剤に有用なイミダゾール基部を有する窒素−硫黄配位子類